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============

**What was known?**

FUMHD is an acute ulceronecrotic form characterized by high fever and large necrotic lesions; new crops may continue to develop over many months.

Pityriasis lichenoides et varioliformis acuta (PLEVA); also known as Mucha-Habermann disease; is an uncommon, idiopathic, acquired dermatosis characterized by erythematous, scaly papules often accompanied by hemorrhagic and papulonecrotic lesions. Febrile ulceronecrotic variant of PLEVA, also termed febrile ulceronecrotic Mucha-Habermann disease (FUMHD), was first described by Degos in 1966. FUMHD is characterized by the acute onset of large, more destructive, coalescent ulceronecrotic skin lesions associated with high fever and other systemic symptoms.

Case Report {#sec1-2}
===========

A 20-year-old male was admitted with 20 days history of fever and reddish lesions on the chest which rapidly progressed to involve the entire body over a period of 14 days. Clinical examination revealed papules, plaques, vesiculobullous and few ulcerative lesions on the chest, back, extremities, palms, soles, and genital mucosa \[[Figure 1](#F1){ref-type="fig"}\].

![Polymorphic lesions occurring in crops on the chest, back, extremities, palms, soles, and genital mucosa](IJD-59-631c-g001){#F1}

On general physical examination patient looked toxic with tachycardia (heart rate = 124/min), tachypnea (respiratory rate 22/min), fever (max. temp. 103.8 F), no lymphadenopathy was noted. Systemic examination revealed no abnormality. Differential diagnosis of vasculitis, erythema multiforme major, FUMHD, and pemphigus foliaceus were considered.

Histopathological examination from papulovesicular lesion revealed epidermal clefts, edema, and vacuolar degeneration of keratinocytes, basal cell degeneration, and dermal perivascular lymphocytic infiltrate without extravasation of RBC \[[Figure 2](#F2){ref-type="fig"}\]. There was transient leucocytosis (TLC-12,300) and elevation of transaminases (serum glutamic oxaloacetic transaminase (SGOT)-50, serum glutamic pyruvic transaminase (SGPT)-63) which returned to normal over a period of 2 weeks. Direct immunoflouroscence, Veneral Disease Research Laboratory test (VDRL), enzyme-linked immunosorbent assay (ELISA) for human immunodeficiency virus (HIV), serology for herpes 1 and 2, Tzanck smear, X-ray chest, and ultrasonography of abdomen were normal. On clinical and histopathological basis, he was diagnosed as a case of FUMHD.

![Epidermal clefts, edema, and vacuolar degeneration of keratinocytes, basal cell degeneration, and dermal perivascular infiltrate (H and E, ×40)](IJD-59-631c-g002){#F2}

There was an initial good response to oral prednisolone 60 mg (1 mg/kg) and oral doxycycline 100 mg twice daily. His steroid was tapered by 10 mg weekly. However, there was a relapse on reducing steroids from 60 to 25 mg over 4 weeks. Methotrexate was added at this stage starting at 7.5 mg gradually increased to 15 mg in 2 weeks, which led to a dramatic response and it was possible to discontinue steroids and doxycycline in another 3 weeks. Patient is in complete remission on maintenance dose of 5 mg methotrexate since past 3 months. It is planned to continue methotrexate in the same dose for another 3 months and then continue follow up for 1 year without treatment. The papules and plaques healed with post-inflammatory hyperpigmentation (PIH) whereas vesiculobullous lesions with varioliform scarring \[[Figure 3](#F3){ref-type="fig"}\].

![Superficial lesions healed with PIH while deeper lesions with varioliform scarring](IJD-59-631c-g003){#F3}

Discussion {#sec1-3}
==========

Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a rare and aggressive form of PLEVA. The etiology of the disease remains uncertain as it is not known yet whether PLEVA is a hypersensitive reaction to hypersensitivity to some infectious agents (HIV, streptococcus, toxoplasma, viral agents), a hypersensitivity vasculitis (immune mediated) or if it is a genuine lymphoproliferative process that is part of the scope of skin lymphoproliferative disorder diseases of the T-cell.\[[@ref1][@ref2][@ref3]\] There is a strong male predominance in FUMHD (about 75%) and most cases occur in the second or third decade of life.\[[@ref4]\]

In the acute ulceronecrotic form, there is high fever and large necrotic lesions; new crops may continue to develop over many months.\[[@ref5]\] About 50-75% of cases occur in adults, with a fulminating course that might even be fatal. General malaise, weakness, myalgia, neuropsychiatric symptoms, and lymphadenopathy occur, with non-specific serological markers of inflammation such as raised erythrocyte sedimentation rate (ESR) and C-reactive protein; there may be serological evidence of associated viral infection.

Histopathological examination in early lesions shows an infiltrate of predominantly small lymphocytes surrounding the walls of dilated dermal capillaries, which show endothelial proliferation along with basal cell vacuolation.\[[@ref4][@ref6]\] Our case showed similar findings. Immunofluorescence studies have variably demonstrated IgM, C3 or fibrin in vessel walls.

Treatment options include antibiotics such as tetracyclines or erythromycin and phototherapy of different types, including natural sunlight, UVB, narrow-band UVB, UVA1 and PUVA. Systemic corticosteroids,\[[@ref7]\] methotrexate,\[[@ref7][@ref8]\] ciclosporin,\[[@ref9]\] and intravenous immunoglobulin have also been tried. Steroid is among the first line treatment for FUMHD.

Our case is unique in terms of unresponsiveness to steroids. We would like to highlight the role of methotrexate in a steroid unresponsive FUMHD. There are only few reports of the use of methotrexate in FUMHD.\[[@ref7][@ref8]\] The best treatment is still not well established due to the small number of published cases.

**What is new?**

Role of methotrexate in a steroid unresponsive FUMHD.
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